(IR) Ingersoll Rand - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US45687V1061
Compressors, Pumps, Blowers, Power Tools, Vacuum
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.09% |
| Yield on Cost 5y | 0.17% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 83.7% |
| Payout Ratio | 2.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Value at Risk 5%th | 40.0% |
| Relative Tail Risk | -6.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.13 |
| Alpha | -27.12 |
| CAGR/Max DD | 0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.379 |
| Beta | 1.190 |
| Beta Downside | 1.100 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.62% |
| Mean DD | 10.10% |
| Median DD | 6.25% |
Description: IR Ingersoll Rand December 17, 2025
Ingersoll Rand Inc. (NYSE: IR) operates globally in two core segments: Industrial Technologies & Services, which supplies air- and gas-compression, vacuum, blower, fluid-transfer, power-tool and lifting equipment (including aftermarket parts and services) under brands such as Gardner Denver, CompAir and Elmo Rietschle; and Precision & Science Technologies, which delivers high-precision pumps, hydrogen compressors, liquid-handling and dosing systems for medical, life-science, industrial and energy markets under brands like Haskel, Milton Roy and LMI.
Key recent metrics show FY 2023 revenue of roughly $13.5 billion, a free-cash-flow conversion of ≈ 85 % of operating cash flow, and an operating margin of ≈ 13 %, with aftermarket services contributing about 30 % of total sales and delivering higher margin stability. The segment’s hydrogen-compression portfolio is benefitting from the global decarbonization push, while the broader industrial-equipment market remains sensitive to U.S. construction-spending cycles and capital-expenditure trends in manufacturing.
For a deeper, data-driven look at how these dynamics translate into valuation risk and upside, you may find a quick scan on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (545.1m TTM) > 0 and > 6% of Revenue (6% = 447.5m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.00% (prev 33.75%; Δ -3.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.38b > Net Income 545.1m (YES >=105%, WARN >=100%) |
| Net Debt (3.68b) to EBITDA (1.67b) ratio: 2.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (400.5m) change vs 12m ago -1.57% (target <= -2.0% for YES) |
| Gross Margin 43.72% (prev 43.81%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.98% (prev 39.32%; Δ 1.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.69 (EBITDA TTM 1.67b / Interest Expense TTM 250.8m) >= 6 (WARN >= 3) |
Altman Z'' 2.09
| (A) 0.12 = (Total Current Assets 4.16b - Total Current Liabilities 1.93b) / Total Assets 18.19b |
| (B) 0.15 = Retained Earnings (Balance) 2.79b / Total Assets 18.19b |
| (C) 0.06 = EBIT TTM 1.18b / Avg Total Assets 18.20b |
| (D) 0.33 = Book Value of Equity 2.63b / Total Liabilities 8.00b |
| Total Rating: 2.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.26
| 1. Piotroski 6.0pt |
| 2. FCF Yield 3.53% |
| 3. FCF Margin 16.75% |
| 4. Debt/Equity 0.48 |
| 5. Debt/Ebitda 2.21 |
| 6. ROIC - WACC (= -3.12)% |
| 7. RoE 5.33% |
| 8. Rev. Trend 90.98% |
| 9. EPS Trend -1.01% |
What is the price of IR shares?
As of January 09, 2026, the stock is trading at USD 84.37 with a total of 2,432,375 shares traded.
Over the past week, the price has changed by +5.78%, over one month by +6.38%, over three months by +4.20% and over the past year by -5.35%.
Over the past week, the price has changed by +5.78%, over one month by +6.38%, over three months by +4.20% and over the past year by -5.35%.
Is IR a buy, sell or hold?
Ingersoll Rand has received a consensus analysts rating of 3.94.
Therefore, it is recommended to buy IR.
- Strong Buy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 88.3 | 4.7% |
| Analysts Target Price | 88.3 | 4.7% |
| ValueRay Target Price | 91.9 | 8.9% |
IR Fundamental Data Overview January 05, 2026
P/E Trailing = 59.0815
P/E Forward = 21.7391
P/S = 4.2504
P/B = 3.1133
P/EG = 1.056
Beta = 1.326
Revenue TTM = 7.46b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 65.6m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.68b USD (from netDebt column, last quarter)
Enterprise Value = 35.38b USD (31.70b + Debt 4.85b - CCE 1.18b)
Interest Coverage Ratio = 4.69 (Ebit TTM 1.18b / Interest Expense TTM 250.8m)
FCF Yield = 3.53% (FCF TTM 1.25b / Enterprise Value 35.38b)
FCF Margin = 16.75% (FCF TTM 1.25b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 1.94 (Enterprise Value 35.38b / Total Assets 18.19b)
Interest Expense / Debt = 1.34% (Interest Expense 65.1m / Debt 4.85b)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 905.4m (EBIT 1.18b * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = 2.21 (Net Debt 3.68b / EBITDA 1.67b)
Debt / FCF = 2.94 (Net Debt 3.68b / FCF TTM 1.25b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 7.84% (EBIT 1.18b / Capital Employed (Equity 10.22b + L.T.Debt 4.79b))
RoIC = 6.04% (NOPAT 905.4m / Invested Capital 14.99b)
WACC = 9.16% (E(31.70b)/V(36.55b) * Re(10.40%) + D(4.85b)/V(36.55b) * Rd(1.34%) * (1-Tc(0.23)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 77.91% ; FCFF base≈1.30b ; Y1≈1.60b ; Y5≈2.73b
Fair Price DCF = 86.43 (EV 37.82b - Net Debt 3.68b = Equity 34.15b / Shares 395.1m; r=9.16% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -1.01 | EPS CAGR: -41.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.98 | Revenue CAGR: 8.92% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=9
EPS next Year (2026-12-31): EPS=3.58 | Chg30d=-0.012 | Revisions Net=-3 | Growth EPS=+8.9% | Growth Revenue=+4.6%
P/E Forward = 21.7391
P/S = 4.2504
P/B = 3.1133
P/EG = 1.056
Beta = 1.326
Revenue TTM = 7.46b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 65.6m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.68b USD (from netDebt column, last quarter)
Enterprise Value = 35.38b USD (31.70b + Debt 4.85b - CCE 1.18b)
Interest Coverage Ratio = 4.69 (Ebit TTM 1.18b / Interest Expense TTM 250.8m)
FCF Yield = 3.53% (FCF TTM 1.25b / Enterprise Value 35.38b)
FCF Margin = 16.75% (FCF TTM 1.25b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 1.94 (Enterprise Value 35.38b / Total Assets 18.19b)
Interest Expense / Debt = 1.34% (Interest Expense 65.1m / Debt 4.85b)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 905.4m (EBIT 1.18b * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = 2.21 (Net Debt 3.68b / EBITDA 1.67b)
Debt / FCF = 2.94 (Net Debt 3.68b / FCF TTM 1.25b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 7.84% (EBIT 1.18b / Capital Employed (Equity 10.22b + L.T.Debt 4.79b))
RoIC = 6.04% (NOPAT 905.4m / Invested Capital 14.99b)
WACC = 9.16% (E(31.70b)/V(36.55b) * Re(10.40%) + D(4.85b)/V(36.55b) * Rd(1.34%) * (1-Tc(0.23)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 77.91% ; FCFF base≈1.30b ; Y1≈1.60b ; Y5≈2.73b
Fair Price DCF = 86.43 (EV 37.82b - Net Debt 3.68b = Equity 34.15b / Shares 395.1m; r=9.16% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -1.01 | EPS CAGR: -41.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.98 | Revenue CAGR: 8.92% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=9
EPS next Year (2026-12-31): EPS=3.58 | Chg30d=-0.012 | Revisions Net=-3 | Growth EPS=+8.9% | Growth Revenue=+4.6%
Additional Sources for IR Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle